18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR-TRC-14005009
正在进行
/
/
/
2014-07-25
/
/
stroke
體外反搏與經顱磁刺激聯合療法對中風病人手部運動功能康復的研究
體外反搏與經顱磁刺激聯合療法對中風病人手部運動功能康復的研究
體外反搏與經顱磁刺激聯合療法對中風病人手部運動功能康復
随机平行对照
Ⅳ期
RCT
/
Division of Neurology, Dept of Medicine and Therapeutics, PWH, The Chinese University of Hong Kong
/
80
/
2014-09-20
1990-01-01
/
1) patients aged 18 or above; 2) first-ever ischemic subcortical stroke with onset time less than 21 days; 3) hand weakness (distal MRC 1- 5-) as a result of stroke; 4) recordable MEPs over ipsilesional hemisphere; 5) intracranial hemorrhage excluded by brain computed tomography (CT) / magnetic resonance imaging (MRI); 6) the patient or his/her legally acceptable representative is willing to provide written informed consent.;
登录查看For TMS : 1) personal history of epilepsy; 2) metallic implants in any part of body; 3) implanted cardiac pacemaker, defibrillator, medication pump or any other implanted electronics; 4) severe skull fracture, serious head injury, history of brain or spinal cord surgery; 5) brain tumour or other significant non-ischemic brain lesion on CT/MRI; 6) administration of drugs that potentially lower seizure threshold; 7) active malignancy; 8) severe co-existing systemic diseases: eg. renal failure (creatinine more than 300 umol/L, if known), cirrhosis, severe dementia or psychosis; 9) inability to be followed up at regular interval; 10) pegnancy or breast-feeding. For ECP: 11) evidence for cardioembolic stroke such as atrial fibrillation and rheumatic heart disease; 12) sustained hypertension (systolic higher than 180mmHg or diastolic higher than 100mmHg); 13) subject has thrombocytopenia (platelet count less than 100,000/mm3); 14) evidence of arteriovenous malformation, arteriovenous fistula or aneurysm; 15) evidence of diabetic retinopathy.;
登录查看Medicine & Therapeutics, The Chinese University of Hong Kong
/
精准药物2024-11-22
亚泰制药2024-11-22
医药时间2024-11-21
一度医药2024-11-21
新药创始人2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
药时空2024-11-21